Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Evo® sEEG System

K-Number: K222404 · 2022-10-20

Decision Date2022-10-20
Product CodeGZL
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Evo® sEEG System is a medical device manufactured by Neuroone Medical Technologies Corp.. It received FDA 510(k) clearance on 2022-10-20 under approval number K222404. The device is classified under product code GZL. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Evo® sEEG System?

Evo® sEEG System is a medical device that received FDA 510(k) clearance on 2022-10-20. It is manufactured by Neuroone Medical Technologies Corp.. The 510(k) number is K222404.

When was Evo® sEEG System approved by the FDA?

Evo® sEEG System received FDA 510(k) clearance on 2022-10-20, under approval number K222404.

What company makes Evo® sEEG System?

Evo® sEEG System is manufactured by Neuroone Medical Technologies Corp..

What is the FDA product code for Evo® sEEG System?

The FDA product code for Evo® sEEG System is GZL.

Other Devices by Neuroone Medical Technologies Corp.

Related Devices (Code: GZL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.